CFC INTERNATIONAL INC
10-Q, 1997-05-08
ADHESIVES & SEALANTS
Previous: SONUS PHARMACEUTICALS INC, 10-Q, 1997-05-08
Next: CFC INTERNATIONAL INC, 10-Q/A, 1997-05-08



10
                          UNITED STATES

               SECURITIES AND EXCHANGE

               COMMISSION

                      WASHINGTON, DC 20549

                           FORM 10-Q
(Mark One)
       X   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF
              THE SECURITIES EXCHANGE ACT OF 1934
               For the quarterly period ended March 31, 1997
           TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)
               OF THE SECURITIES EXCHANGE ACT OF 1934
          For the transition from

                   to Commission File No.

                   027222

                     CFC INTERNATIONAL, INC.

          (Exact name of Registrant as specified in its
          charter) DELAWARE
          36-3434526
     (State or other jurisdiction of              (I.R.S.
Employer
      incorporation or organization)
Identification No.)
      500 State Street, Chicago Heights, Illinois   60411
     Registrants telephone number, including
     area code:                              (708) 891-3456



Indicated by check mark whether the Registrant (1) has filed
all reports  required  to be filed by Section 13 or  15  (d)
of  the Securities  Exchange Act of 1934 during the preceding
12  months (or  for such shorter period that the Registrant was
required  to file  such  reports),                          and
(2) has been subject  to  such  filing
requirements for the past 90 days.

               YES  ( X )                    NO  (     )
As  of  April 30, 1997, the Registrant had issued and

outstanding shares   of   Common  Stock,  par  value  $.01  per

share,   and shares of Class B Common Stock, par value $.01 per

share.





                     CFC INTERNATIONAL, INC.

                     INDEX TO FORM 10-Q
                              
                              
                              
                              
                              
                              
                              
                              

Page
Part I - Financial Information:
  Item 1 - Financial Statements
       Consolidated Balance Sheets - March 31, 1997 and
       December 31, 1996
       3
       Consolidated Statements of Income for the three (3)
       months ended March 31, 1997 and March 31, 1996         4
       Consolidated Statements of Cash Flows for the three (3)
months
       ended March 31, 1997 and March 31, 1996               5

       Notes to Consolidated Financial Statements            6

   Item 2 - Managements Discussion and Analysis of Financial
Conditions and
                Results of Operations                      7-9
Part II - Other Information:

  Item 5 - Other Information                               10


  Item 6 - Exhibits and Reports on Form 8-K               10


  Signatures                                                11


                            Part I
                 Item 1.  Financial Statements
                               
                     CFC INTERNATIONAL, INC.
                 CONSOLIDATED BALANCE SHEET AT
             MARCH 31, 1997 AND DECEMBER 31, 1996
                               
                               
                                                        March
31, December 31,
                                                 1997
1996

(Unaudited)
 ASSETS
 CURRENT ASSETS:
 Cash and cash equivalents                $1,892,952  $927,703
 Accounts receivable, less allowance for doubtful accounts of
  $618,000 and
  $565,000 respectively                   6,414,437   5,996,657
 Employee receivable                       241,630    220,833
 Inventories:
  Raw materials                           1,293,273   837,307
  Work in process                         1,243,384   1,086,308
  Finished goods                          4,670,774   5,142,558
                                          7,207,431   7,066,173
  Prepaid expenses and other current assets           429,155
392,593
  Deferred income taxes                    663,520    663,520
     Total current assets                 16,849,125  15,267,479
 PROPERTY, PLANT AND
  EQUIPMENT, NET                          10,748,804  10,866,717
 Other assets                              537,626          5
  61,085
    Restricted Cash                         998,690
1,510,827
     Total assets                         29,134,245
28,206,108
 LIABILITIES AND STOCKHOLDERS EQUITY
 CURRENT LIABILITIES:
Current portion of long-term debt .....................         $368,124
                                    $
  368,124
 Accounts payable                         2,157,487   2,558,486
Accrued environmental liability           244,937    244,937
 Accrued bonus                             222,900
200,290
 Accrued vacation                          266,591
236,422
    Accrued corporate income taxes          920,857
263,251
 Other accrued expenses and current liabilities       367,488
761,256
     Total current liabilities            4,548,384   4,632,766
 DEFERRED INCOME TAXES                    1,785,740   1,785,740
 LONG-TERM DEBT                           5,543,719   5,564,027
 MINORITY INTEREST IN CFC APPLIED HOLOGRAPHICS        1,223,179
1,145,240
     Total liabilities                    13,101,022  13,127,773
 STOCKHOLDERS EQUITY:
 Voting Preferred Stock, par value $.01 per share, 750 shares
  authorized,
  no shares issued and outstanding               _          _
 Common stock, $.01 par value, 10,000,000 shares authorized
  4,138,019
  and 4,132,605 shares issued at March 31, 1997 and December 31,
  1996                                      41,379     41,326
 Class B common stock, $.01 par value, 750,000 shares
  authorized, 534,030
  shares issued and outstanding at March 31, 1997 and December
  31, 1996                                   5,340      5,340
 Additional paid-in capital               10,183,535
10,139,248
 Retained earnings                        6,142,075
5,110,647
 Cumulative translation adjustment        (148,771)   (27,891)
                                          16,223,558
15,268,670
Less 156,142 treasury shares of common stock, at cost at March
  31, 1997 and
  December 31, 1996                       (190,335)
(190,335)
                                          16,033,223
15,078,335
 CONTINGENCIES
     Total liabilities and stockholders equity        $29,134
  ,245                                  $ 28,206,108


  The accompanying notes are an integral part of the financial
                           statements.
                           
                     CFC INTERNATIONAL, INC.
               CONSOLIDATED STATEMENTS OF INCOME
      FOR THE THREE MONTHS ENDED MARCH 31, 1997 AND 1996
                         RESPECTIVELY
                               
                               
                               
                               
                                         Three Months Ended
March 31,

                                         1997            1996
(Unaudited)

Net sales                              $9,810,048          $
9,540,497
Cost of goods sold                     5,780,563
5,634,729
Gross profit                           4,029,485
3,90
5,768
Marketing and selling expenses         1,066,083
943,420
General and administrative expenses    852,662
882,2
44
Research and development expenses      310,110
318,5
91
Patent litigation expenses                   0
36,889
                                       2,228,855
2,181,144
Operating income                       1,800,630
1,724,624
Other (income) expenses:
  Interest                              76,442
60,438
  Miscellaneous                        (73,275)
(4,543)
                                         3,167
55,895 Income before income taxes and minority interest
1,797,463                                 1,668,729
Provision for income taxes             688,096
645,9
40
                                       1,109,367
1,022,789

Minority interest in loss (income) of CFC Applied
Holographics (77,939)
_
Net Income                             $1,031,428
$
1,022,789


Net  income per share                  $   0.23        $
0.23
Weighted average number of common stock and common stock
  equivalents used in the net income per share calculation
4,517,435                                  4,526,379





  The accompanying notes are an integral part of the
                           financial statements.
                           
                           
                     CFC INTERNATIONAL, INC.
             CONSOLIDATED STATEMENTS OF CASH FLOWS
      FOR THE THREE MONTHS ENDED MARCH 31, 1997 AND 1996
                         RESPECTIVELY
                               
                               
                                             Three Months
Ended March 31,
1997
1996
                                             (Unaudited)

Cash flow from operating activities:
 Net income                            $1,031,428           $
  1,022,789
   Adjustments to reconcile net income to net cash  provided
      by operating activities:
      Depreciation and amortization    521,740
380,518
                 Minority interest in CFC Applied Holographics
77,939                                       0
      Changes in assets and liabilities:
       Accounts receivable             (471,779)
       (303,665)
       Inventories                     (186,848)
(1,09
       1,010)
       Employee receivable             (20,797)
       (57,988)
       Prepaid expenses and other current assets
       (90,503)                         (94,532)
       Accounts payable                (376,901)         1,39
       2,989
                     Accrued income taxes
628,810 577,047
                     Accrued vacation           30,169
10,978
       Accrued bonus                   22,610
       (639,906)
       Accrued expenses and other current liabilities
       (337,705)                        (995,857)
Net cash provided by operating activities
828,163
 201,363

Cash flows from investing activities:
          Additions to property, plant and equipment
                           (387,047)
  (646,407)
  Decrease in restricted cash investment              512,137
0
Net cash used in investing activities           125,090
 (646,407)

Cash flows from financing activities:
 Proceeds from revolving credit agreements             0
  1,720,000
 Repayments of revolving credit agreements                  0
  (1,286,496)
Repayment of term loans               (2,735)         (27,876)
 Repayment of capital lease            (17,573)
  (17,573)
 Proceeds from purchase of stock       44,340
 Distributions to stockholders              0            (800
  ,000)
Net cash used in financing activities           24,032
 (411,945)

Effect of exchange rate changes on cash and cash equivalents
 (12,036)                                   (38,040)
Increase (decrease) in cash and cash eqivalents
965,249
 (895,029)

Cash and cash equivalents:
 Beginning of period                   927,703         916,480
End of Period                           $1,892,952           $
 21,451




  The accompanying notes are an integral part of the financial
                           statements.
                           
                           
                           


                     CFC INTERNATIONAL, INC.

                     NOTES TO CONSOLIDATED

                     FINANCIAL STATEMENTS MARCH 31,

                     1997 AND 1996

                           (Unaudited)

                           

                           

1.   In  the opinion of  management,  the accompanying unaudited
  consolidated  financial  statements contain  all  adjustments
  (consisting of only normal recurring adjustments) necessary to
  present fairly the financial position of the Company as of
  March 31, 1997 and December 31, 1996, the results of operations
  for the three (3) months ended March 31, 1997 and 1996, and
  statements of cash flows for the three (3) months ended March
  31, 1997  and 1996.
  
  
  Results  for an interim period are not necessarily indicative
  of results for the entire year and such results are subject to
  year end adjustments and independent audit.
  
  
2.Certain  comparative prior year amounts in  the  consolidated
  financial  statements  and notes have  been  reclassified  to
  conform with current year presentation.
  
  
3.In  February,  1997 the Financial Accounting Standards  Board


  (FASB) issued Statement No. 128, Earnings Per Share,  which is


  effective  for  periods ending after December  15,  1997.


  Adoption  of FASB No. 128 is not expected to have a  material


  impact on the Companys results of operations.


  


  


  


  


   Item 2.  MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL
               CONDITION AND RESULTS OF OPERATION
               
               
               
               
Overview

The  Company  formulates, manufactures, and  sells  chemically
complex,  transferable multi-layer coatings  for  use  in  many
diversified  markets such as furniture and  building  products,
pharmaceutical  products, transaction cards  (including  credit
cards,  debit  cards,  ATM cards, and  access  cards),  and  on
holographic  authentication seals.   The  Companys  net  sales
increased 66.1% from $22.4 million in 1992 to $37.2 million  in
1996.   During  that period, the Company realized sales  dollar
growth  in  all  of  its  major product lines.   The  Companys
operating income more than doubled over this four-year  period,
increasing from $1.8 million, or 8.0% of net sales in  1992  to
$5.1 million, or 13.6% of net sales in 1996.
The   Company   has  experienced,  and  expects   to   continue
experiencing,  shifts in the relative sales and growth  of  its
various  products  over time.  The Company believes  that  such
shifts are in the ordinary course of business and are
indicative of its focus on specific niche markets.  During the
period from 1992 to 1996, printed products sales rose from
19.6% to 39.3% of net sales.  Pharmaceutical products sales
declined from 26.2% in 1992  to 21.2% of net sales in 1996 due
to the growth of  other product  lines.  Actual pharmaceutical
product sales  increased from $5.9 million in 1992 to $7.9
million in 1996, or an increase of  35.5% over that four-year
period.  Security products  sales increased  from  6.9% in 1992
to 10.3% of net  sales  in  1996. Holographic products grew
from 3.5% in 1992 to 11.6% of net sales in 1996.

The Companys gross profit reflects all direct product costs and
direct   labor,   quality  control,  shipping  and   receiving,
maintenance,  process  engineering,  plant  management,  and  a
substantial  portion  of  the Companys  depreciation  expense.
Selling,  general  and  administrative expenses  are  primarily
composed of sales representatives salaries and related
expenses, commissions   to  sales  representatives,
advertising   costs, management compensation and corporate
audit and legal  expense. Research and development expenses
include salaries of technical personnel, related depreciation,
and experimental materials.


Results of Operation

The  following  table  sets forth, for the  periods  indicated,
certain  items  from  the Companys consolidated  and  combined
financial  statements as a percentage of  net  sales  for  such
period.


                                      Quarter Ended March 31,
                                       1997         1996
                                       
  Net sales                            100.0%       100.0%
  Cost of sales                          58.9         59.1
  Gross profit                           41.1         40.9
  Selling, general and administrative       19.5
19.5
  Research and development                 3.2
3.3
  Operating income                       18.4         18.1
  Interest expense and other             .1               .6
  Income before taxes and minority interest
18.3
17.5
  Provision for income taxes               7.0
6.8
  Minority interest                          .8            _
  Net income                              10.5%
10.7%


Quarter Ended March 31, 1997 Compared to Quarter Ended March
31, 1996

Net sales for the quarter ended March 31, 1997 increased 2.8%
to $9.8 million, from $9.5 million for the quarter ended March
31, 1996.   Printed product sales increased 12.8% to $3.9
million, from $3.4 million primarily due to an increase in the
Companys
market  share.  Pharmaceutical product sales decreased 6.7%  to
$2.1 million, from $2.2 million, primarily due to stagnation in
the  domestic  market.  Security product (magstripe,  signature
panels,  and tipping products for credit cards) sales increased
17.8% to $999,000, from $848,000.  This increase comes
primarily from strong sales of the Companys magstripe product
line.  Sales of simulated metal and other pigmented products
decreased                                                 14.0%
to  $1.5  million, from $1.7 million, as CFC exited markets  in
which  it  could not derive its historic margins.   Holographic
product  sales increased 5.0% to $1.4 million for  the  quarter
ended  March 31, 1997, compared to $1.3 million for the quarter
ended  March 31, 1996, primarily due to the increased sales  to
SmithKline Beecham for holographic packaging for its  Aquafresh
whitening formula toothpaste.

Gross profit for the quarter ended March 31, 1997 increased
3.2% to  $4.0 million, from $3.9 million for the quarter ended
March 31, 1996.  The increase in gross profit was attributable
to the growth in sales and a decrease in raw material costs.
The gross profit margin for the quarter ended March 31, 1997
increased to 41.1% from 40.9% for the quarter ended March 31,
1996.  Although the Company does not fully allocate all costs
on a product line basis,  the  Company  believes that  its
gross  profit  margin typically  is not substantially different
for any of its  major product categories.

Selling,  general, and administrative expenses for the  quarter
ended March 31, 1997 increased 3.0% to $1,919,000 from
$1,863,000 for  the  quarter ended March 31, 1996.  Selling,
general,  and administrative  expenses for the quarter ended
March  31,  1997 increased as a percentage of net sales to
19.6% from 19.5%  for the  quarter ended March 31, 1996.  This
increase in percentage was primarily due to the additional
investment in resources  in the Pacific Rim.




Research and development expenses for the quarter ended March
31, 1997  decreased 2.7% to $310,110 from $318,591 for the
quarter ended March 31, 1996.  Research and development expense
for the quarter ended March 31, 1997 decreased as a percentage
of  net sales, to 3.2%  from 3.3% for the quarter ended March
31, 1996. This decrease in percentage was primarily due to the
increase in net sales and a decrease in R & D operating
expenses.

Operating income for the quarter ended March 31, 1997 increased
4.4%  to $1.8 million, from $1.7 million for the quarter  ended
March  31, 1996.  Operating income for the quarters ended March
31,  1997 increased as a percentage of net sales to 18.4%  from
18.1%  for the quarter ended March 31, 1996.  This increase  is
primarily due to an increase in gross profit.

Interest expense for the quarter ended March 31, 1997 increased
26.5% to $76,442, from $60,438 for the quarter ended March  31,
1996.  This increase was primarily due to the financing of  the
new  eight  station Roto Gravure printing press to service  the
printed products market.

Income taxes for the quarter ended March 31, 1997 increased  to
$688,000  from $646,000 for the quarter ended March  31,  1996.
This was primarily the result of the increase in operating
income and  the holographic business income being fully taxed.
During the first quarter of 1996, the holographic business
utilized  a tax loss carry forward to offset its tax liability.

Net income for the quarter ended March 31, 1997 increased .8%
to $1,031,428, from $1,022,789 for the quarter ended March 31,
1996. This increase in net income is primarily due to the
increase in operating income.
Liquidity and Capital Resources

Working  capital, consisting predominately of  inventories  and
receivables, increased from $10.6 million at December 31, 1996
to $12.3  million at March 31, 1997.  This increase was
primarily caused by a $467,000 increase in trade receivables
due to growth in  the Companys export business, which is
typically sold with longer terms and an increase in inventory
of $184,000 primarily to  support printed products.  Cash
increased from $927,703  at December 31, 1996 to $1,892,952 at
March 31, 1997, primarily due to  the  use  of  the IRB to fund
the Companys  major  capital expenditure  in  1997,  while 1996
capital  expenditures  were financed by cash from operations.

During the first quarter of 1997, the Company made no

borrowings against  the  revolving credit agreement  maintained

with  the Companys primary bank.  This agreement, which expires

April 1, 1998,  provides  for  borrowings of  specified

percentages  of eligible accounts receivable and inventories,

with the total not to  exceed  $4,500,000.  Accordingly, the

borrowings  would  be classified as current liabilities.







                          SIGNATURES

                               

                               

  Pursuant to the requirements of the Securities Exchange Act
  of 1934, the registrant has duly caused this report to be
  signed on  its behalf by the undersigned, thereunto duly
  authorized, on May 1, 1997.
  
  
  
  
                                  CFC INTERNATIONAL, INC.
                                  Dennis W. Lakomy
                                     Vice    President,   Chief
  Financial Officer,
                                  Secretary, and Treasurer
                                  (Principal Financial Officer)
                                  
                                  
                                  
                                  
                                   /s/
                                  Jeffrey E. Norby
                                  Controller
                                  (Principal Accounting
Officer)











<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000949859
<NAME> CFC INTERNATIONAL, INC.
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                       1,892,952
<SECURITIES>                                   998,690
<RECEIVABLES>                                6,979,437
<ALLOWANCES>                                 (565,000)
<INVENTORY>                                  7,207,431
<CURRENT-ASSETS>                            16,849,125
<PP&E>                                      20,229,465
<DEPRECIATION>                             (9,480,661)
<TOTAL-ASSETS>                              29,134,245
<CURRENT-LIABILITIES>                        4,548,384
<BONDS>                                              0
                                0
                                          0
<COMMON>                                    10,039,919
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                29,134,245
<SALES>                                      9,810,048
<TOTAL-REVENUES>                             9,810,048
<CGS>                                        5,780,563
<TOTAL-COSTS>                                2,228,855
<OTHER-EXPENSES>                                 4,664
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              76,442
<INCOME-PRETAX>                              1,719,524
<INCOME-TAX>                                   688,096
<INCOME-CONTINUING>                          1,031,428
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,031,428
<EPS-PRIMARY>                                      .23
<EPS-DILUTED>                                      .23
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission